Atorvastatin Calcium
Product Images NDC 70934-070

6 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 70934-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

70934 069 90 Rev A 01 19

70934 069 90 Rev A 01 19
Atorvastatin Calcium Tablets, 20mg, label for a 90 tablet package by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes prescription-only status, storage instructions, NDC number 70934-069-90, and batch and expiration date placeholders.*
FDA Label Image

Label 1 (70934 070 30 Rev A 01 18)

Label 1 (70934 070 30 Rev A 01 18)
Atorvastatin Calcium Tablets, 10mg, carton label showing 30 tablets. The label lists the National Drug Code (NDC) 70934-070-30 and manufacturer code 62175-890-43. It includes storage instructions to keep at 20°-25°C and to store in a tight, light-resistant container. The product is prescription only and manufactured by Denton Pharma, Inc. DBA Northwind Pharmaceuticals.*
FDA Label Image

Chemical Structure (Atorvastatin Calcium Tablets 1)

Chemical Structure (Atorvastatin Calcium Tablets 1)
Chemical structure of Atorvastatin Calcium, displaying the arrangement of its molecular components including aromatic rings, hydroxyl groups, and calcium ion complexation with water molecules.*
FDA Label Image

Figure 1 (Atorvastatin Calcium Tablets 2)

Figure 1 (Atorvastatin Calcium Tablets 2)
A line graph showing cumulative incidence (%) over time (years) comparing Atorvastatin and placebo. The solid line represents Atorvastatin, and the dashed line represents placebo, with Atorvastatin showing a lower cumulative incidence. The graph includes a hazard ratio (HR=0.64) and p-value (p=0.0005).*
FDA Label Image

Figure 2 (Atorvastatin Calcium Tablets 3)

Figure 2 (Atorvastatin Calcium Tablets 3)
A line chart comparing cumulative hazard percentages over time between Atorvastatin and placebo groups. The horizontal axis represents the time to first primary endpoint in years, up to four years of follow-up. The vertical axis shows cumulative hazard percentages from 0 to 15%. The Atorvastatin group shows a lower cumulative hazard over time compared to the placebo, with a hazard ratio (HR) of 0.63 (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Figure 3 (Atorvastatin Calcium Tablets 4)

Figure 3 (Atorvastatin Calcium Tablets 4)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over time for Atorvastatin 10 mg and 80 mg. The x-axis represents time in years to the first major cardiovascular endpoint, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a 95% confidence interval (0.69-0.89) and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.